Acute myeloid leukemia aml is a clonal disease caused by genetic abberations occurring predominantly in the elderly. Flt3 is a cytokine receptor which belongs to the receptor tyrosine kinase class iii. Dec 18, 2019 internal tandem duplication mutations of the fmslike tyrosine kinase3 flt3itd are some of the most common mutations in acute myeloid leukemia aml, 1 occurring in approximately 30% of all aml cases, 2 and are associated with adverse prognosis in the setting of a normal or intermediate risk karyotypes. Cd5 is the receptor for the cytokine flt3 ligand flt3l. Alterations in the flt3 gene, including internal tandem duplications itds and d835 mutations occur frequently in acute myelogenous leukemia. Studies jewish studies law library and information science, book studies. Detailed annotation on the structure, function, physiology, pharmacology and clinical relevance of drug targets. Flt3 is activated by binding the fmsrelated tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. Intended use the leukostrat flt3 mutation assay is an in vitro diagnostic product intended for pcrbased detection of flt3 activating mutations in patients with acute myelogenous leukemia aml. In synergy with other growth factors, flt3 ligand stimulates the proliferation and differentiation of various blood cell progenitors.
Flt3 ligand is purified by proprietary chromatographic techniques. Apr 15, 2012 internal tandem duplication mutations in flt3, known to be associated with a poor prognosis in acute myeloid leukaemia, are now shown to be a valid therapeutic target for the disease. Subsequently, associations between the mentioned snps, somatic mutations such as flt3 itd, flt3 d835, dnmt3a codon r882, and npm1 4bp dupins. Flt3 d835 mutations confer differential resistance to type ii. Alterations in flt3 gene were detected in 25% 40161 patients. In this study, the incidence and type of flt3 mutation in a large series of thai aml patients were determined.
No data currently exist regarding flt3 mutations in southeast asian patients. Since the food and drug administration approval of imatinib for treatment of chronic myeloid leukemia in 2001, tyrosine kinase inhibitors tkis have become a mainstay in the care of many malignancies. Useful as a prognostic indicator in acute myeloid leukemias. Cancers free fulltext next generation sequencing in aml. Flt3 deletion and deletioninsertion mutations were previously reported in cases of pediatric acute lymphoblastic leukemia, but seldom described in adult acute leukemia. Tyrosineprotein kinase that acts as cellsurface receptor for the cytokine flt3lg and regulates differentiation, proliferation and survival of hematopoietic progenitor cells and of dendritic cells. Fmsrelated tyrosine kinase 3 ligand flt3lg is a protein which in humans is encoded by the flt3lg gene. Between 20 and 30 percent of people with aml have this mutation. Aug 01, 2011 the incidence of flt3 itd mutations and d835 point mutations at 22% and 9% approximates prior studies on the prevalence of flt3 mutations at diagnosis. Flt3 a gene on chromosome q12 that encodes a classiii receptor tyrosine kinase, which regulates haematopoiesis. University of north carolina molecular genetics laboratory 11818, p. Internal tandem duplication mutations of the fmslike tyrosine kinase3 flt3itd are some of the most common mutations in acute myeloid leukemia aml, 1 occurring in approximately 30% of all aml cases, 2 and are associated with adverse prognosis in the setting of a normal or intermediate risk karyotypes.
These aberrations include flt3itd in 35 22% cases and flt3 d835 mutation in 5 cases 3%. Next generation sequencing ngs analysis has led to a deeper genetic understanding of the pathogenesis and the role of recently discovered genetic precursor lesions clonal hematopoiesis of indeterminateoncogenic potential chipchop in the evolution of aml. We investigated the prevalence and clinicobiological. Flt3 d835 master mix tests for tkd region mutations. Monocytic maturation induced by flt3 inhibitor therapy of. Apr 28, 2017 flt3 somatic variants are among the most common driver mutations with the strongest effects on the overall survival in acute myeloid leukemia 1 aml, the most deadly form of leukemia, which is. Flt3 itd and d835 mutations tend to occur in a mutually exclusive manner. We characterized the mutational status of the flt3 tyrosine kinase domain flt3tld in 3082 patients with newly diagnosed aml. Flt3 as a target the fmslike tyrosine kinase 3 flt3 gene was cloned approximately 20 years ago 11, 12, and resides on chromosome 15.
Flt3 belongs to the type iii class of receptor tyrosine kinases, which also includes kit and pdgfr 3, 16, 17. Description fms related receptor tyrosine kinase 3 also known as cd5, flk2, flk2, stk1 species homo sapiens entrez id 2322. Coli is a nonglycosylated, polypeptide chain containing 163 amino acids and having a molecular mass of 18. The fmslike tyrosine kinase3 flt3 is a receptor tyrosine kinase that plays a key role in cell survival, proliferation, and differentiation of hematopoietic stem cells. Methods using a polymerase chain reaction pcragilent 2100. Pathology consultation on gene mutations in acute myeloid leukemia. Mutations of flt3 d835 in exon 20 previously exon 17 were determined as described. Cluster of differentiation antigen 5 cd5 also known as fms like tyrosine kinase 3 flt 3, receptortype tyrosineprotein kinase flt3, or fetal liver kinase2 flk2 is a protein that in humans is encoded by the flt3 gene. Flt3 d835i836 mutations are associated with poor diseasefree. Promotes activation of ras signaling and phosphorylation of downstream kinases, including.
Internal tandem duplication mutations causing constitutive activation of the receptor, the latter being phosphorylated independently of the ligand, had been identified and the flt3 mutations found to be the strongest prognostic factor for overall survival in patients. The future of targeting flt3 activation in aml springerlink. Flt3 internal tandem duplication itd mutations were observed in 24. Flt3 somatic variants are among the most common driver mutations with the strongest effects on the overall survival in acute myeloid leukemia 1. Internal tandem duplication mutations in flt3, known to be associated with a poor prognosis in acute myeloid leukaemia, are now shown to be a. In our series, three patients lost a clone with flt3 mutation at first relapse, two with flt3itd and one with d835 aspartate mutation fig. Mutations of flt3 comprise one of the most frequently identified types of genetic alterations in acute myeloid leukemia. We have purified to homogeneity and partially sequenced a soluble form of the flt3 flk2 ligand produced by mouse thymic stromal cells. Mutation of npm1 and flt3 genes in acute myeloid leukemia. No mutations have been identified in any cases with diagnoses other than aml. Fmsrelated tyrosine kinase 3 ligand flt3lg is a protein which in humans is encoded by the flt3lg gene flt3 ligand fl is a hematopoietic four helical bundle cytokine. The specimen control size ladder master mix targets multiple genes and generates a series of amplicons of approximately 100, 200, 300, 400, and 600 basepairs to ensure that the quality and quantity of input dna is adequate to yield a valid result. Detects the flt3 d835 i836 exon 20 tyrosine kinase domain variant. Flt3 d835 mutations confer differential resistance to type.
While the biological significance of this type of flt3 mutations is unknown in human disease, a small 10amino acid tyr589 to tyr599 deletion in the juxtamembrane domain of flt3 has been previously shown to lead to. They are also closely linked to the murine equivalents of the pdgfra and kit. Frequency and prognostic relevance of flt3 mutations in saudi. Frequency and prognostic relevance of flt3 mutations in. Ligand for flt3 flk2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant rnas. Jcm free fulltext modelling the effects of mcm7 variants. Invivoscribe receives fda approval for the leukostrat cdx.
Pdf prognostic relevance of flt3tkd mutations in aml. The prognostic relevance of fmslike tyrosine kinase 3 flt3 internal tandem duplications and point mutations at d835 in acute promeylocytic leukemia apl is controversial. Review article treatment of flt3itd acute myeloid leukemia. Addgene alerts receive email alerts when new plasmids with this gene become available. The flt3 gene provides instructions for making a protein called fmslike tyrosine kinase 3 flt3, which is part of a family of proteins called receptor tyrosine kinases rtks. Detection of activating mutations in the receptor tyrosine kinase flt3 that occur in 15% of acute myeloid leukemia. Downstream molecular pathways of flt3 in the pathogenesis. Cabozantinib did not reveal any activity against the flt3 d835 tkd point. We investigated whether elimination of this step would still give equivalent results and compared the accuracy of variant allele fraction vaf between polymerase chain reactioncapillary electrophoresis pcrce vs nextgeneration sequencing ngs methods. Flt3itd and flt3tkd d835 16 6% flt3tkd d835 only 5% prior aml lines of therapy 1 75 30%. One of these patients lost a small flt3itd positive clone with an insert of 18 nucleotides at relapse and at the same time relapsed with an apparently unrelated flt3itd positive clone with an. The mutations include an internal tandem duplication itd in the juxtamembrane domain coding sequence and a missense mutation in the kinase domain d835 of the flt3 gene that impart a poor prognosis. Flt3 is activated after binding with its ligand fl, which results in a cascade of tyrosine autophosphorylation and tyrosine phosphorylation of downstream targets 3.
However, a lesser number effectively inhibit the various flt3tkd variants. Cabozantinib is well tolerated in acute myeloid leukemia. Validation of itd mutations in flt3 as a therapeutic target. Inhibitory concentration 50 ic 50 for proliferation of baf3 cells expressing flt3itd d835 mutants profiled for the clinically active flt3. Many commonly used flt3 mutational assay protocols require a tedious blast enrichment step.
Artz reports no relationships to this field of study. Onethird of acute myeloid leukemia patients have mutations of this gene, and the majority of these mutations involve an internal tandem duplication in the juxtamembrane region of flt3, leading to constitutive activation of. This is a challenging prospect because these latter mutations often arise as resistance alterations after initial flt3. Evolution of flt3itd and d835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy article in leukemia research 2810. Internal tandem duplication and asp835 mutations of the fms. As previously noted, d835 is predicted to play a critical role in the stabilization of the dfgout conformation by serving as an aminoterminal capping residue for the short, oneturn. Evolution of flt3itd and d835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy article in leukemia research. Flt3 receptortype tyrosineprotein kinase flt3 precursor. The flt3 receptor consists of an extracellular portion of five immunoglobulinlike. Similarly, the rate of flt3tkd mutation d835 in our study is 4. Flt3ligand is purified by proprietary chromatographic techniques. Establishment of a costeffective method to detect fltitd and d835. Flt3 is expressed on early hematopoietic progenitor cells and supports growth and differentiation within the hematopoietic system 1,2.
Repression of flt3 by pax5 is crucial for bcell lineage commitment. Evolution of flt3itd and d835 activating point mutations in. This hospital does not cater for childbirth or provide childrens services. Mutations of flt3 were first described in 1997 and account for the most frequent molecular mutations in acute myeloid leukemia aml. The secondary objectives were to assess if any relationships existed between the mentioned snps and flt3, dnmt3a, npm1 mutations with clinical outcomes and overall survival os in aml. Flt3 fmslike tyrosine kinase 3 atlas of genetics and. Mutation of npm1 and flt3 genes in acute myeloid leukemia and. Receptor tyrosine kinases transmit signals from the cell surface into the cell through a process called signal transduction. Therefore, the successful targeting of flt3 has tremendous potential to improve. Alterations of flt3 have been reported at a frequency of 25%35% in adult acute myeloid leukemia aml, the most common being an internal tandem duplication itd and a missense change at amino acid position 835 d835 in the kinase domain international journal of hematology 20 976. Type ii inhibitors bind to the conformation coupled to the dfgout position of the kinase al residues 829856 in flt3 14.
None of the samples showed combination of both flt3itd and flt3 d835 mutations. We profiled all d835 substitutions previously reported to cause flt3 tki resistance in patients 1, 5, 6, as well as d835 mutations occurring in patients as cataloged in the sanger cosmic database or the cancer genome atlas. Internal tandem duplication and asp835 mutations of the. Promotes phosphorylation of shc1 and akt1, and activation of the downstream effector mtor. Signalling of flt3 is important for the normal development of haematopoietic stem cells and progenitor cells. Flt3 is a class iii receptor tyrosine kinase rtk structurally related to the receptors for platelet derived growth factor pdgf, colony stimulating factor 1 csf1, and kit ligand kl these rtk contain five immunoglobulinlike domains in the extracellular region and an intracelular tyrosine kinase domain splitted in two by a specific. Detection of flt3 internal tandem duplication and d835. Thirteen 38% of the 34 samples with npm1 mutation had also flt3itd mutation. Flt3 is activated by binding the fmsrelated tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to. The biology and targeting of flt3 in pediatric leukemia. Flt3 ligand protein mouse recombinant sl cytokine prospec.
Activating mutation of d835 within the activation loop of flt3 in human. Cancers free fulltext next generation sequencing in. Artz, md, ms, division of hematologyoncology, university of chicago. First discovered 20 years ago, these mutations were identified as viable therapeutic targets, and flt3 tyrosinekinase inhibitors tkis have been in. Smith cc, american society of clinical oncology educational book. The variant allelic frequency compares the amount of itds to the sum of the mutated and wildtype wt forms of the flt3segment the allelic ratio is the ratio of itds to wt forms the flt3itd mutation allelic ratio appears to be prognostically important, but has not been standardized for clinical decision making. We characterized the mutational status of the flt3 tyrosine kinase domain flt3 tld in 3082 patients with newly diagnosed aml.
Validation of itd mutations in flt3 as a therapeutic. Flt3 ligand fl is a hematopoietic four helical bundle cytokine. Gilteritinib for treatment of pediatric patients with flt3. In acute myeloid leukemia aml, activating mutations in the fmslike tyrosine kinase 3 flt3 gene result in survival and proliferation of leukemic blasts and are associated with adverse. Oct 19, 2019 many commonly used flt3 mutational assay protocols require a tedious blast enrichment step. Briefly, flt3 exon 20 was pcr amplified using the primer pair forward 5.
Plasmids containing this gene, or a homologous gene. Simultaneous flt3, npm1 and dnmt3a mutations in adult patients. Detection of flt3 inframe internal tandem duplications flt3itd mutation is performed as a mailout test sent to a reference laboratory, whereas the assays that detect flt3 point mutations that alter the aspartic acid at position 835 flt3 d835 and the npm1 mutations are performed in the university of iowa molecular pathology laboratory. By using several molecular technologies we found four mutations. Flt3 is a gene change, or mutation, in leukemia cells. Flt3 mutations have been reported to be the most frequent mutation in acute myeloid leukemia aml. Aml patients with flt3 internal tandem duplication itd mutations have poor cure. The d835 mutation is a missense mutation and confers a change in amino acid. Primers were designed to distinguish between wildtype flt3, flt3itd, and d835 variants.
Leukostrat flt3 mutation assay beckman coulter cenat platforms leukostrat flt3 mutation assay megakit beckman coulter cenat platforms 2. Two basic categories of mutation are recognized in flt3. It is expressed on the surface of many hematopoietic progenitor cells. Whether the mutation rate differs at relapse requires further study, as flt3 generally is thought to be a lateacquired event in leukogenesis. The flt3 gene codes for a protein called flt3 that helps white blood cells grow. The flt3 gene has demonstrated ability to predict a patients likelihood to benefit from therapy as well as their risk of experiencing a disease recurrence. Evolution of flt3itd and d835 activating point mutations. Apr 24, 20 since the food and drug administration approval of imatinib for treatment of chronic myeloid leukemia in 2001, tyrosine kinase inhibitors tkis have become a mainstay in the care of many malignancies. Flt3 mutation testing in acute myeloid leukemia genetics. The p85 subunit of pi3 kinase, shp2, grb2 and shc are associated with flt3 after fl stimulation 46. A flt3 mutation is a genetic mutation that may be screened during genetic testing, when diagnosed with aml. Downstream molecular pathways of flt3 in the pathogenesis of.
The flt3 d835 mutations are also ligandindependent, gainoffunction mutations. Internal tandem duplications itd and tyrosinekinase domain tkd mutations of the fmslike tyrosinekinase 3 flt3 can be found in up to one third of patients with acute myeloid leukemia aml and confer a poor prognosis. Thus a total of 24 patients had identifiable flt3 mutations 21 itd, 2 d835, 1 both itd and d835, yielding an overall flt3 mutation rate of 24 of 110, 21. Miseq detected 100 single nucleotide variants and 23 npm1 insertions in. Flt3 d835x indicates any flt3 missense mutation that results in the aspartic acid d at amino acid 835 being replaced by a different amino acid. Molecular diagnostics lab flt3 mutational analysis pcr. Oct 15, 2005 two distinct types of the flt3 mutations were characterized. Promotes activation of ras signaling and phosphorylation of downstream kinases, including mapk1erk2 and.
The potent inhibition of the tkd f691 flt3 variant is an important. It is structurally homologous to stem cell factor scf and colony stimulating factor 1. The microgranular variant m3v form of leukemia was found to be associated with a higher frequency of itd p 0. Inhibitory concentration 50 ic 50 for proliferation of baf3 cells expressing flt3 itd d835 mutants profiled for the clinically active flt3. Mutations of the flt3 gene in adult acute myeloid leukemia. In synergy with other growth factors, flt3 ligand stimulates the proliferation and. The results of our clinical experience are summarized in table 1 1.
825 1662 137 1441 187 67 636 291 1554 1138 1074 1282 1138 1348 756 199 720 308 95 312 1395 1254 1392 200 798 1245 593 1085 137 1057 1028